Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-ß-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Article
in En
| MEDLINE
| ID: mdl-31871075
ABSTRACT
We report a 15 year-old Nigerian adolescent male with chronic osteomyelitis caused by an extensively drug-resistant (XDR) Pseudomonas aeruginosa strain of sequence type 773 (ST773) carrying blaNDM-1 and an extended spectrum ß-lactamase (ESBL)-producing Klebsiella pneumoniae strain. The patient developed neurological side effects in the form of circumoral paresthesia with polymyxin B and asymptomatic elevation of transaminases with aztreonam (used in combination with ceftazidime-avibactam). Cefiderocol treatment for 14 weeks plus bone implantation resulted in apparent cure and avoided amputation.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pseudomonas aeruginosa
/
Surgical Wound Infection
/
Cephalosporins
/
Compassionate Use Trials
/
Klebsiella pneumoniae
/
Anti-Bacterial Agents
Limits:
Adolescent
/
Humans
/
Male
Country/Region as subject:
Africa
Language:
En
Journal:
Antimicrob Agents Chemother
Year:
2020
Type:
Article
Affiliation country:
United States